Wróbel, J.; Zapała, Ł.; Niemczyk, G.; Poleszak, E.; Dobrowolski, P.; Kluz, T.; Bogaczyk, A.; Jasielski, P.; Wdowiak, A.; Bojar, I.;
et al. The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model. Biomolecules 2025, 15, 190.
https://doi.org/10.3390/biom15020190
AMA Style
Wróbel J, Zapała Ł, Niemczyk G, Poleszak E, Dobrowolski P, Kluz T, Bogaczyk A, Jasielski P, Wdowiak A, Bojar I,
et al. The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model. Biomolecules. 2025; 15(2):190.
https://doi.org/10.3390/biom15020190
Chicago/Turabian Style
Wróbel, Jan, Łukasz Zapała, Grzegorz Niemczyk, Ewa Poleszak, Piotr Dobrowolski, Tomasz Kluz, Anna Bogaczyk, Patryk Jasielski, Artur Wdowiak, Iwona Bojar,
and et al. 2025. "The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model" Biomolecules 15, no. 2: 190.
https://doi.org/10.3390/biom15020190
APA Style
Wróbel, J., Zapała, Ł., Niemczyk, G., Poleszak, E., Dobrowolski, P., Kluz, T., Bogaczyk, A., Jasielski, P., Wdowiak, A., Bojar, I., Misiek, M., & Wróbel, A.
(2025). The Efficacy of an Active Medicinal Alkaloid, Berbamine, in Reducing Overactive Bladder Symptoms in a Retinyl Acetate-Induced Model. Biomolecules, 15(2), 190.
https://doi.org/10.3390/biom15020190